210 related articles for article (PubMed ID: 22580604)
1. Prolyl isomerase Pin1 downregulates tumor suppressor RUNX3 in breast cancer.
Nicole Tsang YH; Wu XW; Lim JS; Wee Ong C; Salto-Tellez M; Ito K; Ito Y; Chen LF
Oncogene; 2013 Mar; 32(12):1488-96. PubMed ID: 22580604
[TBL] [Abstract][Full Text] [Related]
2. Prolyl isomerase Pin1 negatively regulates the stability of SUV39H1 to promote tumorigenesis in breast cancer.
Khanal P; Kim G; Lim SC; Yun HJ; Lee KY; Choi HK; Choi HS
FASEB J; 2013 Nov; 27(11):4606-18. PubMed ID: 23934277
[TBL] [Abstract][Full Text] [Related]
3. Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 directly binds and stabilizes Nrf2 in breast cancer.
Saeidi S; Kim SJ; Guillen-Quispe YN; Jagadeesh ASV; Han HJ; Kim SH; Zhong X; Piao JY; Kim SJ; Jeong J; Shin YJ; Cha YJ; Lee HB; Han W; Min SH; Tian W; Kitamura H; Surh YJ
FASEB J; 2022 Jan; 36(1):e22068. PubMed ID: 34918396
[TBL] [Abstract][Full Text] [Related]
4. Prolyl isomerase Pin1 is highly expressed in Her2-positive breast cancer and regulates erbB2 protein stability.
Lam PB; Burga LN; Wu BP; Hofstatter EW; Lu KP; Wulf GM
Mol Cancer; 2008 Dec; 7():91. PubMed ID: 19077306
[TBL] [Abstract][Full Text] [Related]
5. Destabilization of KLF10, a tumor suppressor, relies on thr93 phosphorylation and isomerase association.
Hwang YC; Yang CH; Lin CH; Ch'ang HJ; Chang VHS; Yu WCY
Biochim Biophys Acta; 2013 Dec; 1833(12):3035-3045. PubMed ID: 23994618
[TBL] [Abstract][Full Text] [Related]
6. Prevalent overexpression of prolyl isomerase Pin1 in human cancers.
Bao L; Kimzey A; Sauter G; Sowadski JM; Lu KP; Wang DG
Am J Pathol; 2004 May; 164(5):1727-37. PubMed ID: 15111319
[TBL] [Abstract][Full Text] [Related]
7. Pin1 modulates ERα levels in breast cancer through inhibition of phosphorylation-dependent ubiquitination and degradation.
Rajbhandari P; Schalper KA; Solodin NM; Ellison-Zelski SJ; Ping Lu K; Rimm DL; Alarid ET
Oncogene; 2014 Mar; 33(11):1438-47. PubMed ID: 23542176
[TBL] [Abstract][Full Text] [Related]
8. Prolyl isomerase Pin1 enhances osteoblast differentiation through Runx2 regulation.
Lee SH; Choi YH; Kim YJ; Choi HS; Yeo CY; Lee KY
FEBS Lett; 2013 Nov; 587(22):3640-7. PubMed ID: 24113655
[TBL] [Abstract][Full Text] [Related]
9. The prolyl isomerase Pin1 enhances HER-2 expression and cellular transformation via its interaction with mitogen-activated protein kinase/extracellular signal-regulated kinase kinase 1.
Khanal P; Namgoong GM; Kang BS; Woo ER; Choi HS
Mol Cancer Ther; 2010 Mar; 9(3):606-16. PubMed ID: 20179161
[TBL] [Abstract][Full Text] [Related]
10. Peptidyl-prolyl isomerase 1 (Pin1) serves as a coactivator of steroid receptor by regulating the activity of phosphorylated steroid receptor coactivator 3 (SRC-3/AIB1).
Yi P; Wu RC; Sandquist J; Wong J; Tsai SY; Tsai MJ; Means AR; O'Malley BW
Mol Cell Biol; 2005 Nov; 25(21):9687-99. PubMed ID: 16227615
[TBL] [Abstract][Full Text] [Related]
11. Pin1 is overexpressed in breast cancer and cooperates with Ras signaling in increasing the transcriptional activity of c-Jun towards cyclin D1.
Wulf GM; Ryo A; Wulf GG; Lee SW; Niu T; Petkova V; Lu KP
EMBO J; 2001 Jul; 20(13):3459-72. PubMed ID: 11432833
[TBL] [Abstract][Full Text] [Related]
12. Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.
Khanal P; Yun HJ; Lim SC; Ahn SG; Yoon HE; Kang KW; Hong R; Choi HS
Oncogene; 2012 Aug; 31(34):3845-56. PubMed ID: 22158035
[TBL] [Abstract][Full Text] [Related]
13. Pin1 regulates centrosome duplication, and its overexpression induces centrosome amplification, chromosome instability, and oncogenesis.
Suizu F; Ryo A; Wulf G; Lim J; Lu KP
Mol Cell Biol; 2006 Feb; 26(4):1463-79. PubMed ID: 16449657
[TBL] [Abstract][Full Text] [Related]
14. Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α.
Rajbhandari P; Ozers MS; Solodin NM; Warren CL; Alarid ET
J Biol Chem; 2015 May; 290(22):13749-62. PubMed ID: 25866209
[TBL] [Abstract][Full Text] [Related]
15. Pin1 overexpression is associated with poor differentiation and survival in oral squamous cell carcinoma.
Leung KW; Tsai CH; Hsiao M; Tseng CJ; Ger LP; Lee KH; Lu PJ
Oncol Rep; 2009 Apr; 21(4):1097-104. PubMed ID: 19288014
[TBL] [Abstract][Full Text] [Related]
16. Degradation of the tumor suppressor PML by Pin1 contributes to the cancer phenotype of breast cancer MDA-MB-231 cells.
Reineke EL; Lam M; Liu Q; Liu Y; Stanya KJ; Chang KS; Means AR; Kao HY
Mol Cell Biol; 2008 Feb; 28(3):997-1006. PubMed ID: 18039859
[TBL] [Abstract][Full Text] [Related]
17. The prolyl isomerase Pin1 in breast development and cancer.
Wulf G; Ryo A; Liou YC; Lu KP
Breast Cancer Res; 2003; 5(2):76-82. PubMed ID: 12631385
[TBL] [Abstract][Full Text] [Related]
18. A critical step for JNK activation: isomerization by the prolyl isomerase Pin1.
Park JE; Lee JA; Park SG; Lee DH; Kim SJ; Kim HJ; Uchida C; Uchida T; Park BC; Cho S
Cell Death Differ; 2012 Jan; 19(1):153-61. PubMed ID: 21660049
[TBL] [Abstract][Full Text] [Related]
19. The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response.
Zheng H; You H; Zhou XZ; Murray SA; Uchida T; Wulf G; Gu L; Tang X; Lu KP; Xiao ZX
Nature; 2002 Oct; 419(6909):849-53. PubMed ID: 12397361
[TBL] [Abstract][Full Text] [Related]
20. Oxygen-independent stabilization of HIF-2α in breast cancer through direct interaction with peptidyl-prolyl cis-trans isomerase NIMA-interacting 1.
Guillen-Quispe YN; Kim SJ; Saeidi S; Zhou T; Zheng J; Kim SH; Fang X; Chelakkot C; Rios-Castillo ME; Shin YK; Surh YJ
Free Radic Biol Med; 2023 Oct; 207():296-307. PubMed ID: 37473874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
